Related Experiment Video

Updated: Feb 7, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.2K

Immune-mediated encephalitis with daclizumab: The final nail

Thomas Williams1, Jeremy Chataway1

  • 1Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|August 4, 2018
PubMed

Abstract:

We provide clinical commentary on this edition's case report of immune-mediated encephalitis related to daclizumab therapy.

Keywords:
Daclizumabencephalitismultiple sclerosis

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.0K

Related Experiment Videos

Last Updated: Feb 7, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.2K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.0K

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.1K
Overview
84.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.5K
Accessory Structures of the Skin: Nails01:05

Accessory Structures of the Skin: Nails

3.4K
Nails are one of the important accessory structures of the skin. They are hard, protective structures that cover the dorsal surface of the distal phalanges of fingers and toes. Nails are composed of specialized keratinized cells and serve various functions, including protection, sensation, and manual dexterity.
The main components of a nail include the following.
Nail Plate: The nail plate is the visible portion of the nail that extends beyond the fingertips or toes. It is a hard, translucent...
3.4K
What is the Immune System?01:38

What is the Immune System?

130.5K
Overview
130.5K
Humoral Immune Responses01:36

Humoral Immune Responses

84.0K
Overview
84.0K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

111.0K
Overview
111.0K
Keywords:
Daclizumabencephalitismultiple sclerosis

Articles linked to this work by shared authors, journal, and citation graph.

Developing Interim Outcome Measures for Multi-Arm Multistage Clinical Trials in Multiple Sclerosis.

Neurology·2026

B-cell repopulation and postpartum MS disease activity following ofatumumab cessation for pregnancy in women with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial.

Brain communications·2026

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026

The clinical, radiological and genetic spectrum AARS2-related leukoencephalopathy: a case series of 15 patients and review of the literature.

Journal of neurology·2026

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI.

Neuroradiology·2026

A group resilience training program for people with multiple sclerosis: A cluster-randomized controlled trial (multi-READY for MS).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Cesarean sections prior to 39 weeks among pregnant patients with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Racial disparities in multiple sclerosis quality of care metrics.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Ultra-processed foods and multiple sclerosis: Evidence, pitfalls and perspectives.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MS.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Impact of multiple sclerosis symptoms survey: Patient-reported data on the prevalence, burden, and management of multiple sclerosis symptoms in Europe.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Lupus nephritis at systemic lupus erythematosus onset and kidney outcomes in a Latin American biopsy-proven cohort.

Lupus·2026

Diffuse Large B-Cell Lymphoma Presenting as an Infiltrative Masticator Space Lesion Mimicking Inflammatory Disease: A Case Report.

Cureus·2026

Astragaloside IV Modulates the Immune Response in Rheumatoid Arthritis and is Associated with Inhibition of the NAV2-Wnt/β-Catenin Signaling Cascade.

Journal of inflammation research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us